BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 4280525)

  • 1. Results of prolonged treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP).
    De Vries HR; Bijvoet OL
    Neth J Med; 1974; 17(6):281-98. PubMed ID: 4280525
    [No Abstract]   [Full Text] [Related]  

  • 2. Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment.
    Smith R; Russell RG; Bishop MC; Woods CG; Bishop M
    Q J Med; 1973 Apr; 42(166):235-56. PubMed ID: 4206518
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings: Treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1,1-diphosphonate.
    de Vries HR; Bijvoet OL; Froeling PG
    J Endocrinol; 1975 Mar; 64(3):51P. PubMed ID: 805820
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of Paget's disease with diphosphonate (disodium ethydronate)].
    Caniggia A; Gennari C; Guideri R; Vattimo A; Nardi P
    Minerva Med; 1976 Jan; 67(1):1-15. PubMed ID: 814505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paget's bone disease treated with diphosphonate and calcitonin.
    Hosking DJ; Bijvoet OL; van Aken J; Will EJ
    Lancet; 1976 Mar; 1(7960):615-7. PubMed ID: 55896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone tissue in Paget's disease treated by ethane-1, hydroxy-1, 1 diphosphonate (EHDP). Structure, ultrastructure, and immunocytology.
    Basle MF; Rebel A; Renier JC; Audran M; Filmon R; Malkani K
    Clin Orthop Relat Res; 1984 Apr; (184):281-8. PubMed ID: 6423333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined diphosphonate and calcitonin therapy for Paget's disease of bone.
    Hosking DJ; Bijvoet OL
    Calcif Tissue Res; 1976 Aug; 21 Suppl():321-6. PubMed ID: 821599
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnosis and treatment of Paget's disease of bone.
    Siris ES
    Compr Ther; 1983 Sep; 9(9):47-53. PubMed ID: 6226474
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
    Alexandre C; Chapuy MC; Bressot C; Vignon E; Arlot M; Mathieu L; Edouard C; Johnston CC; Meunier PJ
    Nouv Presse Med; 1980 Nov; 9(45):3429-33. PubMed ID: 6777752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
    Jung A; Mermillod B; Schenk R; Courvoisier B; Burkhardt P; Epiney J; Fleisch
    Schweiz Med Wochenschr; 1976 Nov; 106(48):1667-73. PubMed ID: 827810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical, biological and histological effects of ethane-1-hydroxy 1, 1-diphosphonate (EDHP) in Paget's disease].
    Meunier P; Chapuy MC; Courpron P; Vignon E; Edouard C; Bernard J
    Rev Rhum Mal Osteoartic; 1975 Nov; 42(11):699-705. PubMed ID: 817385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of Paget's disease of bone: diphosphonates or calcitonin?].
    Davoine GA; Jung A; Courvoisier B
    Schweiz Med Wochenschr; 1981 Apr; 111(15):518-24. PubMed ID: 6785879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of Paget's disease].
    Agrest A
    Medicina (B Aires); 1979; 39(2):275-6. PubMed ID: 159393
    [No Abstract]   [Full Text] [Related]  

  • 14. [Non-hormonal drug treatment in Paget's disease].
    Ryckewaert A; Lemaire V; Tubiana M
    Rev Rhum Mal Osteoartic; 1975 Nov; 42(11):693-8. PubMed ID: 131365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic sequences calcitonin-EHDP and EHDP-calcitonin in Paget's disease. Histological and biological study].
    Eisinger J; Laponche AM; Ouaniche J
    Rev Rhum Mal Osteoartic; 1986 Mar; 53(3):183-5. PubMed ID: 3085204
    [No Abstract]   [Full Text] [Related]  

  • 16. Small doses of etidronate (EHDP) and Paget's disease: meaning and importance of the decrease in plasmatic 25(OH)D3.
    D'Amore M; Carrozzo M; Cantatore FP; Scagliusi P; Pipitone V
    Panminerva Med; 1984; 26(1):13-7. PubMed ID: 6233523
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans).
    Altman RD; Johnston CC; Khairi MR; Wellman H; Serafini AN; Sankey RR
    N Engl J Med; 1973 Dec; 289(26):1379-84. PubMed ID: 4201876
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: Disodium ethane-1-hydroxy-1, 1-diphosphonate(E.H.D.P.) in Paget's disease.
    Fromm G; Schajowicz F; Mautalen CA
    Lancet; 1975 Oct; 2(7936):666. PubMed ID: 52045
    [No Abstract]   [Full Text] [Related]  

  • 19. Radionuclide uptake studies of bone: a quantitative method of evaluating the response of patients with Paget's disease to diphosphonate therapy.
    Goldman AB; Braunstein P; Wilkinson D; Kammerman S
    Radiology; 1975 Nov; 117(2):365-9. PubMed ID: 809805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: Diphosphonate and calcitonin in Paget's disease.
    Hosking DJ; Bijvoet OL
    Lancet; 1976 May; 1(7966):970. PubMed ID: 57380
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.